This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,447.45 delivery order contract is for the provision of Olmesartan Medoxomil 40 mg tablets, a cardiovascular medication. The contract has a firm fixed price and runs through December 4, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. The IDC serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any small business set-aside designations, indicating open competition. This delivery order is part of AmerisourceBergen's broader role as a key vendor for federal healthcare programs, particularly within the military and veterans' health systems.
Generated 3/4/25, 11:27 AM